Press Releases

National Brain Tumor Society (NBTS) Statement on Dr. Ned Sharpless This morning, Norman E. “Ned” Sharpless, M.D., announced his decision to step down as Director of the National Cancer Institute (NCI), a position he has held since 2017, on April 29, 2022. NCI Principal Deputy Director Douglas R. Lowy, M.D., will serve as NCI’s acting director following Dr. Shapless’s departure.  The following is a statement […] April 4, 2022

Brain Tumor Research Funding Takes a Step Forward in FY 2022 Omnibus Spending Bill National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, is pleased to see a number of important government agencies and programs receive much-needed funding increases in Congress’s FY 2022 omnibus appropriations bill.  “Members of Congress from both parties continue to demonstrate that cancer research, including brain tumors, is […] March 15, 2022

National Brain Tumor Society Launches DNA Damage Response Consortium with Yale Consortium seeks to advance underdeveloped area of brain cancer research, advance drug development, and improve treatment options for patients Today, the National Brain Tumor Society (NBTS) announced the launch of its new flagship research initiative, the DNA Damage Response Consortium, in partnership with Yale Cancer Center. The consortium will bring together a diverse team of […] February 22, 2022

National Brain Tumor Society Welcomes New Members to its Board of Directors National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced the addition of four new members to its Board of Directors. The appointments bolster the diversity, experience, and insights of the NBTS Board. The new directors, who join 16 other members in the governance of the organization, […] July 7, 2021

National Brain Tumor Society Statement on President Biden’s FY 2022 Budget National Brain Tumor Society’s (NBTS) chief executive officer David Arons, JD, today released the following statement applauding the inclusion of an ARPA-H program in President Joe Biden’s Fiscal Year 2022 Budget, and urging bipartisan congressional support of medical research funding:  “As a leading proponent of the need for cancer research funding, President Biden has dedicated […] May 28, 2021